Clinical Trials on Primary Hyperoxaluria Type 2 in Austria
Total 1043 results
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Alnylam PharmaceuticalsActive, not recruitingPrimary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Italy, France, Lebanon, Belgium, Netherlands, Israel, United Arab Emirates, Australia, Jordan, Turkey
-
Medical University of ViennaUnknownType2 Diabetes MellitusAustria
-
Landsteiner InstitutMedical University of Vienna; Lund University Hospital; Mein Hanusch-Krankenhaus and other collaboratorsCompletedType 2 Diabetes MellitusAustria
-
Landsteiner InstitutLund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaboratorsCompletedType 2 Diabetes Mellitus | Insulin ResistanceAustria
-
Medical University of ViennaNot yet recruitingUrolithiasis | HyperoxaluriaAustria
-
Paracelsus Medical UniversityCompletedType 2 Diabetes MellitusAustria
-
Medical University of GrazCompletedHealthy | Obesity | Type 2 Diabetes Mellitus | Type 1 DiabetesAustria
-
Ionis Pharmaceuticals, Inc.Completed
-
CeQur CorporationInternational Diabetes Center at Park NicolletCompletedType 2 Diabetes MellitusAustria
-
University of ViennaUnknownCancer | Type 2 DiabetesAustria
-
Medical University of GrazCompletedHyperglycemia | Diabetes Mellitus Type 2Austria
-
Medical University of GrazCompleted
-
Medical University of GrazCompleted
-
CeQur CorporationTerminatedType 2 Diabetes MellitusAustria
-
Medical University of ViennaCompletedType 2 Diabetes MellitusAustria
-
CeQur CorporationCompletedType 2 Diabetes MellitusAustria
-
Medical University of ViennaUnknownType 2 Diabetes Mellitus | Endothelial Dysfunction | Cardiovascular RiskAustria
-
MetaCure LimitedUnknownType 2 DiabetesAustralia, Austria, Greece, Italy, Poland, Serbia
-
German Diabetes CenterCompleted
-
Medical University of ViennaAstraZenecaCompletedType2 Diabetes | Steatosis, LiverAustria
-
Medical University of ViennaCompleted
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
Medical University of ViennaNational Bank of AustriaUnknownInsulin Resistance | Diabetes Mellitus Type 2Austria
-
Medical University of GrazCompleted
-
Paracelsus Medical UniversityCompletedCoronary Artery Disease | Type 2 Diabetes MellitusAustria
-
Medical University of GrazCompleted
-
Allena PharmaceuticalsTerminatedEnteric HyperoxaluriaUnited States, Spain, United Kingdom, Portugal, Romania, Canada, Austria, Belgium, Brazil, Croatia, France, Germany, Italy, Mexico, Russian Federation, Switzerland
-
Medical University of GrazCompletedObesity | Type 2 Diabetes MellitusAustria
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedDiabetes Mellitus Type 2Austria
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Medical University of ViennaSt. Vincent Hospital, ViennaCompletedDiabetes Type 2 | Postmenopausal OsteoporosisAustria
-
Solvay PharmaceuticalsCompleted
-
Alexandra Kautzky-WillerBayerRecruitingFatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes MellitusAustria
-
SynlogicCompletedEnteric HyperoxaluriaUnited States
-
Monash UniversityUniversity of Victoria; University of Auckland, New ZealandCompleted
-
Medical University of ViennaUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Healthy Volunteers | Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) | Familiar Hypocalcuric HypercalcemiaAustria
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus (T2DM)United States
-
Medical University of ViennaUnknownType 2 Diabetes | Metabolically Healthy ControlsAustria
-
MetaCure LimitedCompleted
-
Medical University of GrazCompletedDiabetes Mellitus, Type IIAustria
-
HighTide Biopharma Pty LtdCompleted
-
Medical University of ViennaCompletedDiabetes Mellitus Type IIAustria
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceActive, not recruitingType 2 Diabetes Mellitus | Pre DiabetesAustralia
-
QL Biopharmaceutical Australia Pty LtdNovotech (Australia) Pty Limited; Beijing QL Biopharmaceutical Co.,LtdRecruiting
-
St. Pölten University of Applied SciencesKarl Landsteiner University of Health Sciences; Austrian Health Insurance FundActive, not recruitingDiabetes Mellitus, Type 2 | Peer Support | Instant Messaging ServiceAustria
-
Royal Perth HospitalRecruitingObesity | Type 2 Diabetes Mellitus | Metabolic SyndromeAustralia
-
Medical University of GrazCompletedDiabetes Mellitus, Type 2Austria
-
Bayside HealthBaker Heart Research Institute; International Diabetes Institute, AustraliaTerminated